This study aimed to use the anti-inflammatory properties of silymarin to reduce inflammation caused by rheumatoid arthritis determined by reducing anti-CCP and hs-CRP inflammatory factors and possibly increase the anti-inflammatory factor CTRP3, which is thought to have a protective role in rheumatoid arthritis. This evidence concerns the gene C1QTNF3 and rheumatoid arthritis.